Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05663502 · ClinicalTrials.gov registry record
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
A clinical trial of Lymphoma and Malignant Solid Neoplasm, sponsored by AIDS Malignancy Consortium.
- Recruiting
- Registry status
- 200
- Enrollment target
- 8
- Study locations
NCT05663502: Recruiting study of Lymphoma and Malignant Solid Neoplasm, sponsored by AIDS Malignancy Consortium.
NCT05663502 is a study of Lymphoma and Malignant Solid Neoplasm that is actively recruiting participants, run by AIDS Malignancy Consortium. The registered enrollment target is 200 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (59% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05663502, a study of Lymphoma and Malignant Solid Neoplasm, is actively recruiting participants, sponsored by AIDS Malignancy Consortium.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
Primary Outcome
The number of blood and tissue specimens will be counted.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (8)
California
- UC San Diego Moores Cancer Center - La Jolla
- University of California, San Francisco - San Francisco
New York
- Mount Sinai Hospital - New York
- Memorial Sloan Kettering Cancer Center - New York
District of Columbia
- George Washington University - Washington D.C.
Florida
- University of Miami - Miami
Maryland
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore
Utah
- Huntsman Cancer Institute, University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2035-08-31 |
What NCT05663502 shows while recruiting
NCT05663502 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (59% lower).
The record links to 10 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT05663502 lists 8 locations in 6 states (California, New York, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT05663502 about?
NCT05663502 is a clinical study titled "Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers". This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors relat...
What is the current status of trial NCT05663502?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-05-10. Estimated completion is 2035-08-31.
What conditions does trial NCT05663502 study?
This clinical trial studies the following conditions: Lymphoma, Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Kaposi Sarcoma.
What interventions are being tested in trial NCT05663502?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT05663502?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05663502 being conducted?
This trial has 8 study locations across California, District of Columbia, Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05663502's enrollment target sits among peer trials
200 48th of 299 higher than 252 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI